0000891293-15-000033.txt : 20150923 0000891293-15-000033.hdr.sgml : 20150923 20150923171402 ACCESSION NUMBER: 0000891293-15-000033 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20150921 FILED AS OF DATE: 20150923 DATE AS OF CHANGE: 20150923 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CTI BIOPHARMA CORP CENTRAL INDEX KEY: 0000891293 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 911533912 STATE OF INCORPORATION: WA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3101 WESTERN AVENUE STREET 2: SUITE 600 CITY: SEATTLE STATE: WA ZIP: 98121 BUSINESS PHONE: 2062827100 MAIL ADDRESS: STREET 1: 3101 WESTERN AVENUE STREET 2: SUITE 600 CITY: SEATTLE STATE: WA ZIP: 98121 FORMER COMPANY: FORMER CONFORMED NAME: CELL THERAPEUTICS INC DATE OF NAME CHANGE: 19960321 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: SINGER JACK W CENTRAL INDEX KEY: 0001204264 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-12465 FILM NUMBER: 151121561 MAIL ADDRESS: STREET 1: 501 ELLIOT AVENUE WEST STREET 2: SUITE 400 CITY: SEATTLE STATE: WA ZIP: 98119 4 1 primary_doc.xml PRIMARY DOCUMENT X0306 4 2015-09-21 0 0000891293 CTI BIOPHARMA CORP ctic 0001204264 SINGER JACK W 3101 WESTERN AVE SUITE 600 SEATTLE WA 98121 1 1 0 0 EVP, Global Medical Affairs Common Stock 2015-09-21 4 A 0 205931 0 A 1466850 D As disclosed by CTIC in a form 8-K filed on 1/31/14, CTIC granted a bonus opportunity to the reporting person that is payable in shares of CTIC common stock upon the achievement of certain performance goals. This transaction reflects the issuance of common stock by CTIC pursuant to the award in connection with CTIC's determination that the Pacritinib Phase III goal under the award has been satisfied. By: Louis A. Bianco, Attorney-in-fact For: Jack W. Singer 2015-09-23